Profil
Claus Crone Fuglsang est Chief Scientific Officer & Executive VP chez Novozymes A. Il a obtenu un diplôme d'études supérieures de l'université de Copenhague et un MBA de l'Edinburgh Business School.
Postes actifs de Claus Crone Fuglsang
| Sociétés | Poste | Début |
|---|---|---|
Microbiogen Pty Ltd.
Microbiogen Pty Ltd. BiotechnologyHealth Technology Develops non-genetically modified yeast | Directeur/Membre du Conseil | - |
Anciens postes connus de Claus Crone Fuglsang
| Sociétés | Poste | Fin |
|---|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Directeur Technique/Scientifique/R&D | 01/02/2024 |
| BIOPORTO A/S | Directeur/Membre du Conseil | 01/01/2014 |
Formation de Claus Crone Fuglsang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microbiogen Pty Ltd.
Microbiogen Pty Ltd. BiotechnologyHealth Technology Develops non-genetically modified yeast | Health Technology |
Edinburgh Business School
Edinburgh Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















